Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

completed267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completed

18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis

NCT04073875
completedphase_1

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

NCT02864810
terminatedphase_1

Evaluation of a New Imagingtechnologie for Thrombosis

NCT02469376

Clinical Trials (3)

Showing 3 of 3 trials
NCT04073875

18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis

Completed
NCT02864810Phase 1

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

Completed
NCT02469376Phase 1

Evaluation of a New Imagingtechnologie for Thrombosis

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3